Home › Sindromi mielodisplastiche › New York
Studi clinici su Sindromi mielodisplastiche nello stato di New York
38 studi su Sindromi mielodisplastiche cercano partecipanti presso sedi nello stato di New York.
Città nello stato di New York
- New York City21 studi
- The Bronx9 studi
- Buffalo8 studi
- Rochester6 studi
- Queens6 studi
- Greenburgh5 studi
- New Rochelle3 studi
- Staten Island3 studi
Testo ufficiale dello studio (inglese)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Roswell Park Cancer Institute, Buffalo
- Stony Brook University Medical Center, Stony Brook
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06577441Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06484062A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età da 12 a 78 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT03802695MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Northwell Health/Center for Advanced Medicine, Lake Success
- e altri 9
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Hematology Oncology Associates of Rockland, Nyack
- Albert Einstein College - Montefiore, The Bronx
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT07422480Collection of Tissue Samples for Cancer Research
- Roswell Park Cancer Institute, Buffalo
In reclutamentoStudio osservazionale
2 Months · Tutti i sessi · Aggiornato il 16 set 2026 · NCT00900198A Telehealth Advance Care Planning Intervention
- University of Rochester, Rochester
In reclutamento
Età 60 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT05875805Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età da 21 a 65 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT05884333Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- MSKCC, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06465953The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- e altri 7
In reclutamentoFase 1/2
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Northwell Health, Lake Success
- Clinical Research Alliance NY, Westbury
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06499285A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- New York Cancer and Blood, Shirley
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT04419649ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- NYU Langone Health, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT06656494Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
- Ichan School of Medicine at Mount Sinai, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT05308264Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
In reclutamentoFase 1/2
Età 16 e oltre · Tutti i sessi · Aggiornato il 20 lug 2026 · NCT07155226Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Albany Medical Center, Albany
In reclutamentoStudio osservazionale
Fino a 30 anni · Tutti i sessi · Aggiornato il 16 lug 2026 · NCT04968834Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 lug 2026 · NCT07216443Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Wilmot Cancer Institute, University of Rochester, Rochester
In reclutamentoFase 1 iniziale
Età da 18 a 75 · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT03964506Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
In reclutamentoFase 2
Fino a 26 anni · Tutti i sessi · Aggiornato il 14 mag 2026 · NCT07566377A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York University Langone Hospital - Long Island, Mineola
- Perlmutter Cancer Center - 34th Street, New York
- e altri 2
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 apr 2026 · NCT04256317A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
- Icahn School of Medicine at Mount Sinai, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 apr 2026 · NCT06146257A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- The University of Rochester, Rochester
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 apr 2026 · NCT05732103Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 mar 2026 · NCT07107126A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 mar 2026 · NCT04988555FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Montefiore Medical Center, The Bronx
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 mar 2026 · NCT07283094CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Roswell Park Cancer Institute, Buffalo
- New York University, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 gen 2026 · NCT05143996Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM), The Bronx
In reclutamentoFase 1
Età da 18 a 75 · Tutti i sessi · Aggiornato il 8 gen 2026 · NCT05342584Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- Montefiore Medical Center, The Bronx
- White Plains Hospital, White Plains
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 gen 2026 · NCT05184842Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- Montefiore Medical Center, The Bronx
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 dic 2025 · NCT04245397Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
- Montefiore Medical Center, The Bronx
In reclutamentoFase 1Volontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 nov 2025 · NCT05986240SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- e altri 2
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774Umbilical Cord Blood Transplantation From Unrelated Donors
- Wilmot Cancer Institute, Rochester
In reclutamentoStudio osservazionale
2 Months – 75 Years · Tutti i sessi · Aggiornato il 10 ott 2025 · NCT03016806A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2025 · NCT06501196Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
- University of Rochester Medical Center, Rochester
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2025 · NCT01311258Study of REM-422 in Patients With AML or Higher Risk MDS
- Memorial Sloan Kettering, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 apr 2025 · NCT06297941Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 apr 2025 · NCT06462365A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Memorial Sloan-Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 mar 2024 · NCT04243785Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.